MedTrace Logo

Response to Diaphragmatic Pacing in Subjects With Pompe Disease

NCT02354651 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2023-08-01

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the effect of diaphragm pacing on respiratory function in subjects with Pompe disease by evaluating the duration and pattern of spontaneous respiratory function versus paced ventilation respiratory function in patients with Pompe disease who have received the NeuDx Diaphragm pacer (DPS).

Conditions

  • Pompe Disease

Interventions

OTHER

Diaphragm conditioning via phrenic nerve stimulation

Diaphragm pacing will be prescribed by the patient's clinical team.

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • University of Florida

    lead OTHER

Principal Investigators

  • Barbara K Smith, PT, PhD · University of Florida

Eligibility

Min Age
2 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2022-06-30
Completion
2023-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02354651 on ClinicalTrials.gov